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The antigen preparation most often used for determining the levels of antibodies to virulence-associated
proteins of Shigella spp. consists of a mixture of proteins (including IpaB, IpaC, IpaD, and VirG*) extracted
from virulent shigellae with water (water extract). To overcome the lack of specificity for individual antigens
in the water-extract enzyme-linked immunosorbent assay (ELISA), the ipaD gene from S. flexneri has been
cloned, expressed to a high level, and purified for use in a new ELISA for the determination of the levels of
antibody against IpaD in monkeys and humans challenged with shigellae. The IpaD ELISA for serum
immunoglobulins G and A correlated well with the water-extract ELISA in that monkeys infected with S.
flexneri or S. sonnei responded with high serum antibody titers in both assays. The IpaD assay required less
antigen per well, had much lower background levels, and did not require correction with antigens from an
avirulent organism. In conjunction with the water-extract ELISA, it was possible to identify infected animals
that did not respond to IpaD but did produce antibodies that reacted in the water-extract ELISA. This
indicates that even though IpaB, IpaC, and IpaD are essential for the invasiveness phenotype, the infected host
does not always produce antibodies against all components of the invasiveness apparatus.
Bacillary dysentery is a severe diarrheal disease caused by
Shigella species. Several essential virulence factors of Shigella
spp., including the invasion plasmid antigen (Ipa) proteins
(IpaB, IpaC, and IpaD), VirG (IcsA), and lipopolysaccharide
(LPS) elicit substantial antibody responses in the serum as well
as in secretions after infection (1, 5, 6, 10, 11, 13). The most
frequently used serological assays for measuring the antibody
response against Shigella protein antigens are Western blots
(immunoblots) and enzyme-linked immunosorbent assays
(ELISAs). Western blots provide qualitative and semiquanti-
tative information about antibodies against specific protein
antigens, but they must be interpreted carefully. For example,
in the IpaB region of blots, three serologically recognized an-
tigens, including IpaB, IpaH, and HSP60, exist. The titers of
antibodies are more readily determined by ELISAs. Two an-
tigens routinely used in ELISAs for Shigella serodiagnosis are
purified LPS (which must be prepared for each Shigella sero-
type to be analyzed) and the water-extractable antigens (1, 5,
10, 13). The latter antigen preparation is a heterogenous prod-
uct which includes both invasiveness plasmid antigens (IpaB,
IpaC, IpaD, and VirG*) and chromosomally encoded proteins
and LPS (9, 10, 15). This antigen preparation is frequently used
for measuring antibody levels in serum and secretions as well
as for the detection of circulating antibody-secreting cells pro-
ducing antibodies against the virulence-specific antigen com-
plex (3, 4). It can be used for any species of Shigella or entero-
invasive Escherichia coli because the ipa genes are conserved in
all serotypes. Unfortunately, it does not measure antibody lev-
els against specific Ipa proteins or VirG, and it requires a
correction for antibodies against chromosomally encoded pro-
teins. This is accomplished by preparing a water extract from a
plasmid-free Shigella strain that is the same serotype as the
virulent preparation. To overcome the shortcomings of the
water-extract ELISA, we have developed a new ELISA using
purified, recombinant IpaD protein. IpaD is present in the
water extract from virulent organisms and is a crucial factor in
the invasiveness of shigellae (7, 9, 10). It is located in the outer
membrane of shigellae, is exposed on the surface, and is pos-
sibly involved in the modulation of secretion of IpaB and IpaC
(7, 9, 10). The IpaD ELISA, described here, will provide spec-
ificity and sensitivity in serological assays for monitoring the
immune response to virulence-associated antigens after infec-
tion with shigellae. This will be useful in determining infection
with Shigella spp. in nonimmune humans and higher primates
in outbreaks of diarrheal disease as well as in seroprevalence
surveys.
The PCR was used to produce a 1,000-bp ipaD fragment for
insertion into the plasmid expression vector pET-15b. Primers,
based on the published nucleotide sequence of ipaD (14), were
designed to give an ipaD-containing DNA fragment that could
be inserted in frame into pET-15b after each was NdeI-BamHI
digested. The resulting PCR product was treated with NdeI
and BamHI and ligated into NdeI-BamHI-digested pET-15b.
E. coli BL21(DE3)pLysS was transformed with the ligation
mixture, and transformants were selected on Luria-Bertani
agar containing 0.03 mg of ampicillin per ml. Transformants
were screened for inserts by the appearance of a 1,000-bp PCR
product by using the T7 RNA polymerase promoter and ter-
minator sequences as primers. Insertion of the ipaD fragment
was confirmed by double-stranded DNA sequencing.
Overexpression of the resulting ipaD fusion gene in E. coli
BL21 (DE3)pLysS was possible with IPTG (isopropyl-b-D-
thiogalactopyranoside) induction (Fig. 1). The fusion protein
product with a size of about 42 kDa (Fig. 1) consisted of
full-length IpaD fused to a 3-kDa leader peptide containing six
histidine residues. This leader peptide enabled the fusion pro-
tein to be affinity purified by passing a cytosolic extract, con-
taining the recombinant protein, over a Ni21 column followed
by elution of the IpaD fusion protein with 1 M imidazole. The
IpaD fusion protein was approximately 95% pure as deter-
mined with Coomassie-stained gels, and it reacted with three
different rabbit anti-IpaD serum samples made against three
different IpaD peptides (9).* Corresponding author. Phone: (202) 782-3010. Fax: (202) 782-0748.
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To date it has not been possible to measure antibody levels
against individual Ipa proteins in an ELISA because of the lack
of pure, stable Ipa proteins. To establish the usefulness of the
IpaD ELISA, we compared the serum antibody levels against
IpaD, water-extracted antigens, and LPS in monkeys infected
with S. flexneri 2a.
Purified IpaD, diluted in phosphate-buffered saline (PBS;
pH 7.4), was used to coat polystyrene 96-well plates (Corning/
Costar, Cambridge, Mass.) at a final concentration of 0.05 mg
per well. The antigen was incubated on the plates overnight at
48C. The wells were subsequently blocked with 2% casein in a
Tris-buffered saline solution. Immune sera, diluted in casein,
were incubated with the antigen for 2 h. After the wells were
washed with PBS containing 0.05% Tween 20, alkaline phos-
phatase-conjugated anti-human immunoglobulin G (IgG) or
IgA (Kirkegaard & Perry, Gaithersburg, Md.) was added for 1
h, the wells were washed, and finally, the substrate (para-
nitrophenylphosphate, 1 mg/ml in diethanolamine buffer) was
added to each well and allowed to develop for 30 min. All
incubations with antisera and washes were performed at room
temperature. The optical density (OD) was determined with a
Molecular Dynamics microplate reader at a wavelength of 405
nm. The levels of serum antibodies against LPS and virulence-
associated antigens extracted with water were measured with
an ELISA, as previously described (10).
Antibody levels to IpaD, water extract, and LPS were deter-
mined for sera collected from 47 monkeys from four different
treatment groups, 2 weeks after infection with S. flexneri 2a
(Table 1). The quantity of shigellae administered orally ranged
from 2 3 103 CFU per monkey to 2 3 109 CFU per monkey,
with each successive group of 12 monkeys receiving 100-fold-
more shigellae. The various doses of shigellae gave a range of
immune responses and clinical disease. The baseline anti-IpaD
levels were uniformly low for all monkeys. Infection with lower
doses of shigellae (2 3 103 and 2 3 105 CFU) did not produce
disease and resulted in a minimal serum antibody response. At
the highest dose (23 109 CFU per monkey), 10 of 11 monkeys
had diarrhea, 10 of 11 produced serum IgG antibodies against
IpaD, and all 11 were positive for IgG antibodies against the
water extract (Table 1). Similar responses for IgA against IpaD
and IgG for LPS were found. The level of response against LPS
appeared somewhat lower in the group of animals receiving 2
3 107 CFU. The data in Fig. 2 indicate that a correlation
FIG. 1. Affinity purification of the IpaD-fusion protein. E. coli
BL21(DE3)pLysS harboring the recombinant plasmid pWPD10 was induced
with IPTG, resulting in the appearance of a protein observed on Coomassie-
stained sodium dodecyl sulfate–10% polyacrylamide gels with an apparent mo-
lecular mass of 42 kDa (lane 2). No such protein species was observed in
uninduced cells (lane 1). The crude cytosolic extract was passed over an immo-
bilized support to which Ni21 had been reversibly chelated. The column was
washed extensively, and the IpaD fusion protein eluted with the same buffer
containing 1 M imidazole. The purified IpaD fusion protein (lane 3), prepared in
this way, was routinely greater than 95% pure as judged with Coomassie-stained
sodium dodecyl sulfate-polyacrylamide gels. Molecular mass standards (in the
unmarked lane) are 212, 158, 116, 97, 66, 56, 43, 37, 26, and 20 kDa, respectively,
from top to bottom.
FIG. 2. Correlation between the IpaD ELISA and the water extract ELISA.
A total of 47 serum samples were collected from monkeys 2 weeks after oral
challenge with S. flexneri 2a. All serum samples were diluted 1/800 for this
analysis and were probed with an anti-IgG conjugate. A comparison of the
optical density values obtained for the IpaD ELISA versus those for the water-
extract ELISA is shown (r of 0.942, P of ,0.0001). The solid line represents the
best fit obtained by regression analysis.
TABLE 1. Serological response to IpaD, water extract, and LPS in monkeys challenged with various doses of S. flexneri 2a
Dose (CFU) No. of animals infected/no. testeda
Mean OD 6 SDb No. of animals that seroconverted against antigenindicated/no. testedc
IpaD/IgG IpaD/IgA
IpaD (IgG)d IpaD (IgA)d Water extract LPSd
Preinfection Postinfection Preinfection Postinfection
2.0 3 103 0/12 0.26 6 0.21 0.23 6 0.17 0.44 6 0.67 0.37 6 0.60 0/12 0/12 0/12 0/12
2.0 3 105 0/12 0.33 6 0.48 0.34 6 0.37 0.46 6 1.01 0.49 6 0.97 1/12 1/12 2/12 0/12
2.0 3 107 2/12 0.62 6 0.73 1.67 6 1.01d 0.25 6 0.18 0.82 6 0.63d 8/12 8/12 7/12 4/12
2.0 3 109 10/11 0.32 6 0.18 2.52 6 1.27d 0.19 6 0.19 0.93 6 0.80d 10/11 8/11 11/11 10/11
aMonkeys exhibiting diarrhea within 72 h of infection were considered positive for disease (infected) due to the Shigella challenge.
b The mean OD values at a 1/1,000 dilution of the preinfection and postinfection serum samples are given. The postinfection serum samples were collected 14 days
after challenge.
c The various antigens used to determine the serological response included purified recombinant IpaD, water-extractable virulence-associated antigens (water
extract), and LPS from S. flexneri 2a. IgA and IgG levels were determined against IpaD. Only the IgG level was determined against water extract and LPS. Positive
samples represent those serum samples which had a twofold-higher OD value in the postinfection serum sample than in the preinfection serum sample.
d The difference between the mean OD values was statistically significant, as determined by the Wilcoxon signed rank test (P , 0.005).
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between the IpaD and water-extract ELISA (r of 0.942, P of
,0.0001) existed when IgG levels were determined. Even
though the relationship between the IpaD (IgG) ELISA and
the water-extract (IgG) ELISA was very strong, there were two
monkeys (of 47) that had serum IgG antibodies to the water-
extracted antigens but not to IpaD. Sera from these monkeys
did not react with IpaD on Western blots but did react with
IpaB and IpaC (data not shown). Regression analysis between
the LPS and IpaD ELISA and the LPS and water-extract
ELISA gave r values of 0.814 (P of ,0.0001) and 0.809 (P of
,0.0001), respectively.
The water-extract ELISA is useful in determining antibody
responses against all members of the genus Shigella in large
part because the ipa genes, which encode the dominant anti-
gens in the water extract, are conserved in all invasive Shigella
spp. and enteroinvasive E. coli. The data in Table 2 indicate
that, as expected, monkeys infected with either S. sonnei or S.
flexneri produced serum antibodies against IpaD. Interestingly,
2 of the 12 S. flexneri-infected monkeys did not show increased
levels of IgG against IpaD in serum collected 9 days postin-
fection. Similar to the single animal in the group inoculated
with 2 3 109 CFU, these two animals did produce antibodies
against the water extract, and specifically against IpaB and
IpaC (as determined by Western blot analysis) (9).
In this study, we demonstrated that purified, recombinant
IpaD can be used to monitor the specific immune response in
monkeys infected with a Shigella sp. The assay requires small
quantities of antigen, has low background levels, and is specific
for IpaD. Unlike the water-extract ELISA, it does not require
correction with an antigen from an avirulent source because it
uses a pure antigen. In addition, the recombinant IpaD is
expressed to high levels in the pET15b vector, is relatively
stable (compared with the easily degraded IpaB and IpaC),
and is easy to purify via affinity chromatography on a nickel
column.
The IpaD ELISA correlated very well with the water-extract
ELISA, which was expected since IpaD is present in the water
extract. It was noted that a few monkeys infected with shigellae
did not produce detectable antibodies in the IpaD ELISA but
were positive in the water-extract ELISA. These serum sam-
ples, which were all evaluated by Western blot, were negative
for IpaD and positive for IpaB and IpaC antibodies (9). The
ability of the water-extract ELISA to pick up more positives
than the IpaD ELISA is very likely related to a higher fre-
quency of antibody responses against IpaB and IpaC in in-
fected animals. Therefore, it is unlikely that the IpaD ELISA
can replace the water-extract ELISA but that it will be useful
because of its specificity for IpaD and the lack of background
problems. Sensitivity approaching that of the water-extract
ELISA will likely occur when purified IpaB or IpaC becomes
available. Even so, by using the water-extract ELISA along
with the IpaD ELISA, it is possible to identify subgroups of
infected individuals that have unique immunological responses
to the Ipa proteins. The ability to distinguish subgroups of
infected individuals will enable a better understanding of the
host immune response to Shigella infection. In addition, these
results indicate that all components of the invasiveness protein
complex of Shigella spp. (7, 8) are not recognized equally by all
infected animals.
The IpaD ELISA may also be useful for seroepidemiological
studies designed to identify populations with a high or low
frequency of exposure to Shigella spp. without the need to
consider multiple serotypes of the genus Shigella. For example,
in a group of healthy, adult U.S. citizens, the incidence of
individuals with IpaD antibodies was approximately 15% (9).
A similar frequency was noted for antibodies against the water
extract. In areas of endemicity, the frequency of IpaD antibod-
ies in an adult population would probably be much higher (11,
13).
As other plasmid-encoded antigens, such as IpaB, IpaC, and
VirG, are purified, it will be possible to evaluate the specific
immune response both at the humoral and the totally unchar-
acterized cellular level for each of these components. This type
of information, in conjunction with more-detailed analysis at
the peptide level (12), may be necessary for determining im-
mune response patterns that are correlated with disease out-
come or protection against future disease.
We thank L. Van de Verg and K. R. Turbyfill for helpful comments
and suggestions concerning the manuscript and F. Puente for technical
assistance.
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